CRP Level Associated with The Severity Of COVID-19 Disease

Abstract

The variables influencing the development of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in patients with coronavirus disease 2019 (COVID-19) are still unknown. The purpose of this study was to find these characteristics among COVID-19 patients who were recovering. Between January 15 and March 30, 2022, patients who were (investigated or examined) at Lalav Hospital were included in this study. 100 SARS-CoV-2-infected patients were all enrolled; 51% (51 cases) of the patients were female and 49% (49 cases) of the patients were male. Between the ages of 22 and 81. Sixty-one percent (61/100) of the patients had elevated CRP. P.Value (0.001). The severity of COVID-19 is positively correlated with serum CRP levels, and greater CRP levels were associated with longer hospital stays. For the first time, it is shown that CRP levels can help distinguish between patients with mild to moderate COVID-19 and those with more severe conditions.